Atlas Trials

Suramin in Treating Patients With Refractory or Relapsed Multiple Myeloma or Castleman's Disease

Clinical trial NCT00002652 · COMPLETED

Trial details

NCT number
NCT00002652
Sponsor
University of Arkansas
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma and Plasma Cell Neoplasm
Start date
1995-05-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.